[PERSON]

Leandro Safatle

Featured in 2 tracked stories · first seen about 1 month ago

Situations

[ACTIVE] [HEALTH] [US] [BR] [GB]

GLP-1 drugs: clinical trends, safety, and market shifts

246 clusters · 892 sources · last updated 1 day ago

Latest: Medical experts propose management system for GLP-1 obesity drugs

Since mid-2026, the expansion of GLP-1 agents for obesity has been accompanied by intensified safety monitoring and evolving clinical data. Research suggests secondary benefits, including a 21% lower risk of fragility fr

[QUIET] [HEALTH] [BR] [PY]

Brazil cannabis-derived CBD regulation

2 clusters · 8 sources · last updated 21 days ago

Latest: Anvisa and Dinavisa sign agreement to combat illegal products

Brazil’s National Health Surveillance Agency (Anvisa) is finalizing new regulations to govern the magistral manipulation of cannabidiol (CBD) preparations. The agency has classified this regulatory work as a priority to